- Home
- REPX vs BME Comparison
REPX vs BME Comparison
Compare REPX & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Company Overview
Basic Information| Metric | REPX | BME |
|---|---|---|
| Founded | 2016 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Trusts Except Educational Religious and Charitable |
| Sector | Energy | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 587.9M | 545.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | REPX | BME |
|---|---|---|
| Price | $26.75 | $42.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | ★ 280.4K | 34.0K |
| Earning Date | 03-04-2026 | 01-01-0001 |
| Dividend Yield | 5.75% | ★ 6.26% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.07 | 1.44 |
| Revenue | ★ $397,398,000.00 | N/A |
| Revenue This Year | $0.59 | N/A |
| Revenue Next Year | $14.96 | N/A |
| P/E Ratio | ★ $6.84 | $28.37 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $21.98 | $35.53 |
| 52 Week High | $36.18 | $43.20 |
Technical Indicators
Market Signals| Indicator | REPX | BME |
|---|---|---|
| Relative Strength Index (RSI) | 44.71 | 56.40 |
| Support Level | $27.50 | $41.84 |
| Resistance Level | $29.19 | $42.35 |
| Average True Range (ATR) | 1.10 | 0.47 |
| MACD | -0.12 | -0.03 |
| Stochastic Oscillator | 15.85 | 75.10 |
Price Performance
Historical Comparison REPX
BME
About REPX Riley Exploration Permian Inc.
Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations are in Kansas Properties and Tennessee Properties, among others.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.